- Report
- June 2026
- 181 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 180 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 189 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 233 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 170 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 181 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 162 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 188 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 208 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 286 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 281 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 184 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 212 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 194 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 193 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 376 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 192 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 179 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 306 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 150 Pages
Global
From €5275EUR$5,850USD£4,575GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more